Skip to content
The Mumbai

Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To ₹264 Crore

Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To ₹264 Crore
Photo: Free Press Journal · view original

Mumbai: Glenmark Pharmaceuticals on Thursday reported a 56.7 per cent year-on-year (YoY) decline in consolidated net profit to Rs 264 crore for the quarter ended September 2026 (Q2 FY27), compared with Rs 610 crore in the corresponding period last financial year (Q2 FY26). The drugmaker’s revenue...

Sources and story details